The role of endothelial-mesenchymal transition in heterotopic ossification - PubMed (original) (raw)

Review

. 2012 Aug;27(8):1619-22.

doi: 10.1002/jbmr.1691. Epub 2012 Jul 2.

Affiliations

Review

The role of endothelial-mesenchymal transition in heterotopic ossification

Damian Medici et al. J Bone Miner Res. 2012 Aug.

Abstract

Heterotopic ossification (HO) is a process by which bone forms in soft tissues, in response to injury, inflammation, or genetic disease. This usually occurs by initial cartilage formation, followed by endochondral ossification. A rare disease called fibrodysplasia ossificans progressiva (FOP) allows this mechanism to be induced by a combination of genetic mutation and acute inflammatory responses. FOP patients experience progressive HO throughout their lifetime and form an ectopic skeleton. Recent studies on FOP have suggested that heterotopic cartilage and bone is of endothelial origin. Vascular endothelial cells differentiate into skeletal cells through a mesenchymal stem cell intermediate that is generated by endothelial-mesenchymal transition (EndMT). Local inflammatory signals and/or other changes in the tissue microenvironment mediate the differentiation of endothelial-derived mesenchymal stem cells into chondrocytes and osteoblasts to induce HO. We discuss the current evidence for the endothelial contribution to heterotopic bone formation.

Copyright © 2012 American Society for Bone and Mineral Research.

PubMed Disclaimer

Conflict of interest statement

Disclosures

The authors state that they have no conflicts of interest.

Figures

Fig. 1

Fig. 1

A schematic diagram of the proposed mechanism of EndMT-induced heterotopic ossification. Endothelial cells from capillary blood vessels in muscle tissue undergo EndMT in response to inflammation and an activating mutation in ALK2 in patients with FOP. Cytokines such as BMP2, BMP4, or TGF-β2 can mimic the effects of the ALK2 mutation, while proteins such as BMP7 and VEGF, or a chemical inhibitor of ALK2 like dorsomorphin, can prevent EndMT. These endothelial-derived mesenchymal stem-like cells (MSCs) differentiate into chondrocytes and osteoblasts in response to inflammatory signals. Chondrogenesis occurs first, followed by endochondral ossification.

References

    1. Kaplan FS, Shen Q, Lounev V, Seemann P, Groppe J, Katagiri T, Pignolo RJ, Shore EM. Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP) J Bone Miner Metab. 2008;26:521–530. - PMC - PubMed
    1. Potter BK, Burns TC, Lacap AP, Granville RR, Gajewski DA. Heterotopi ossification following traumatic and combat-related amputations. Prevalence, risk factors, and preliminary results of excision. J Bone Joint Surg Am. 2007;89:476–486. - PubMed
    1. Dudley AC, Khan ZA, Shih SC, Kang SY, Zwaans BM, Bischoff J, Klagsbrun M. Calcification of multipotent prostate tumor endothelium. Cancer Cell. 2008;14:201–211. - PMC - PubMed
    1. Shore EM, Kaplan FS. Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP) Bone. 2008;43:427–433. - PMC - PubMed
    1. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, Choi IH, Connor JM, Delai P, Glaser DL, LeMerrer M, Morhart R, Rogers JG, Smith R, Triffitt JT, Urtizberea JA, Zasloff M, Brown MA, Kaplan FS. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38:525–527. - PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources